ArticleFrontiers in pharmacology2025

E1231/NMN protects against experimental metabolic syndrome: the central role of SIRT1 in modulating AKT/Nrf2/NFκB signaling.

Elsayed A Elmorsy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.